These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 2861078

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Somatostatin desensitization: loss of the ability of somatostatin to inhibit cyclic AMP accumulation and adrenocorticotropin hormone release.
    Reisine T.
    J Pharmacol Exp Ther; 1984 Apr; 229(1):14-20. PubMed ID: 6142943
    [Abstract] [Full Text] [Related]

  • 4. Pertussis toxin blocks somatostatin inhibition of calcium mobilization and reduces the affinity of somatostatin receptors for agonists.
    Reisine T, Guild S.
    J Pharmacol Exp Ther; 1985 Dec; 235(3):551-7. PubMed ID: 2867203
    [Abstract] [Full Text] [Related]

  • 5. Pertussis toxin treatment blocks the inhibition of somatostatin and increases the stimulation by forskolin of cyclic AMP accumulation and adrenocorticotropin secretion from mouse anterior pituitary tumor cells.
    Reisine T, Zhang YL, Sekura R.
    J Pharmacol Exp Ther; 1985 Jan; 232(1):275-82. PubMed ID: 2856941
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Somatostatin receptors in the rat adrenal cortex: characterization and comparison with brain and pituitary receptors.
    Srikant CB, Patel YC.
    Endocrinology; 1985 May; 116(5):1717-23. PubMed ID: 2859190
    [Abstract] [Full Text] [Related]

  • 9. Somatostatin inhibits corticotropin-releasing factor-stimulated adrenocorticotropin release, adenylate cyclase, and activation of adenosine 3',5'-monophosphate-dependent protein kinase isoenzymes in AtT20 cells.
    Litvin Y, Leiser M, Fleischer N, Erlichman J.
    Endocrinology; 1986 Aug; 119(2):737-45. PubMed ID: 2426087
    [Abstract] [Full Text] [Related]

  • 10. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
    Dorflinger LJ, Schonbrunn A.
    Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
    [Abstract] [Full Text] [Related]

  • 11. Multiple mechanisms of somatostatin inhibition of adrenocorticotropin release from mouse anterior pituitary tumor cells.
    Reisine T.
    Endocrinology; 1985 Jun; 116(6):2259-66. PubMed ID: 2859983
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a biotinylated somatostatin analog as a receptor probe.
    Schonbrunn A, Lee AB, Brown PJ.
    Endocrinology; 1993 Jan; 132(1):146-54. PubMed ID: 8093437
    [Abstract] [Full Text] [Related]

  • 13. Prolonged somatostatin pretreatment desensitizes somatostatin's inhibition of receptor-mediated release of adrenocorticotropin hormone and sensitizes adenylate cyclase.
    Reisine T, Axelrod J.
    Endocrinology; 1983 Aug; 113(2):811-3. PubMed ID: 6135600
    [Abstract] [Full Text] [Related]

  • 14. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor.
    Westendorf JM, Schonbrunn A.
    Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986
    [Abstract] [Full Text] [Related]

  • 15. Forskolin stimulates adenylate cyclase activity, cyclic AMP accumulation, and adrenocorticotropin secretion from mouse anterior pituitary tumor cells.
    Heisler S, Reisine T.
    J Neurochem; 1984 Jun; 42(6):1659-66. PubMed ID: 6144727
    [Abstract] [Full Text] [Related]

  • 16. Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism.
    Viguerie N, Tahiri-Jouti N, Ayral AM, Cambillau C, Scemama JL, Bastié MJ, Knuhtsen S, Estève JP, Pradayrol L, Susini C.
    Endocrinology; 1989 Feb; 124(2):1017-25. PubMed ID: 2563240
    [Abstract] [Full Text] [Related]

  • 17. Evidence for multiple protein constituents of the somatostatin receptor in pituitary tumor cells: affinity cross-linking and molecular characterization.
    Murthy KK, Srikant CB, Patel YC.
    Endocrinology; 1989 Aug; 125(2):948-56. PubMed ID: 2568926
    [Abstract] [Full Text] [Related]

  • 18. Somatostatin pretreatment desensitizes somatostatin receptors linked to adenylate cyclase and facilitates the stimulation of cyclic adenosine 3':5'-monophosphate accumulation in anterior pituitary tumor cells.
    Reisine TD, Takahashi JS.
    J Neurosci; 1984 Mar; 4(3):812-9. PubMed ID: 6142935
    [Abstract] [Full Text] [Related]

  • 19. Somatostatin inhibits multireceptor stimulation of cyclic AMP formation and corticotropin secretion in mouse pituitary tumor cells.
    Heisler S, Reisine TD, Hook VY, Axelrod J.
    Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6502-6. PubMed ID: 6128732
    [Abstract] [Full Text] [Related]

  • 20. Muscarinic cholinergic receptors in mouse pituitary tumor cells: prolonged agonist pretreatment decreases receptor content and increases forskolin- and hormone-stimulated cyclic AMP synthesis and adrenocorticotropin secretion.
    Heisler S, Desjardins D, Nguyen MH.
    J Pharmacol Exp Ther; 1985 Jan; 232(1):232-8. PubMed ID: 2981317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.